Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innovex International (INVX) EBT (2016 - 2025)

Innovex International's EBT history spans 17 years, with the latest figure at $27.0 million for Q4 2025.

  • For Q4 2025, EBT rose 103.97% year-over-year to $27.0 million; the TTM value through Dec 2025 reached $128.5 million, up 122.79%, while the annual FY2025 figure was $128.5 million, 122.79% up from the prior year.
  • EBT reached $27.0 million in Q4 2025 per INVX's latest filing, down from $58.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $80.0 million in Q3 2024 to a low of -$679.3 million in Q4 2024.
  • Average EBT over 5 years is -$27.0 million, with a median of $9.3 million recorded in 2022.
  • Peak YoY movement for EBT: soared 285.31% in 2022, then crashed 872.18% in 2024.
  • A 5-year view of EBT shows it stood at -$81.9 million in 2021, then skyrocketed by 175.74% to $62.1 million in 2022, then tumbled by 212.59% to -$69.9 million in 2023, then plummeted by 872.18% to -$679.3 million in 2024, then surged by 103.97% to $27.0 million in 2025.
  • Per Business Quant, the three most recent readings for INVX's EBT are $27.0 million (Q4 2025), $58.0 million (Q3 2025), and $22.2 million (Q2 2025).